One of the biggest challenges we see in life sciences AI today isn't the models. It's the foundation.
Life sciences teams are working with enormous volumes of complex data. Omics, imaging, EHRs, trial protocols, and real-world evidence. Much of it unstructured and governed under strict regulatory requirements.
At the same time, organizations are trying to move beyond isolated AI experiments toward systems that can reliably support scientific and clinical decisions.
That requires more than another proof of concept. It requires patterns that can scale.
That's why I'm excited to share the partnership between Salt AI and Cloudera.
Cloudera provides a trusted data and compute foundation with strong governance, lineage, and security across hybrid environments. On top of that, Salt adds a contextual orchestration layer that connects data, models, tools, and workflows so AI systems can actually operate together.
The next generation of enterprise AI, especially in regulated industries, depends on this kind of architecture. Not just running models, but enabling data talking to models, models talking to other models, models interacting with tools and systems. All with full context, telemetry, and governance.
Together, Cloudera and Salt AI provide a reference architecture for organizations that want to move from isolated AI experiments to durable, trustworthy AI systems that can accelerate discovery and innovation.
For life sciences teams, that means a clearer path to turning complex biological and clinical data into actionable intelligence. And ultimately, getting breakthroughs to patients faster.
If you're interested in how this architecture works in practice, Andreas Skouloudis and I shared more details here:
https://lnkd.in/gjs7tUqd
